A. A. McLean

2.0k total citations
37 papers, 1.5k citations indexed

About

A. A. McLean is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, A. A. McLean has authored 37 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Epidemiology, 16 papers in Immunology and 8 papers in Infectious Diseases. Recurrent topics in A. A. McLean's work include Virology and Viral Diseases (11 papers), Hepatitis B Virus Studies (11 papers) and Immunodeficiency and Autoimmune Disorders (9 papers). A. A. McLean is often cited by papers focused on Virology and Viral Diseases (11 papers), Hepatitis B Virus Studies (11 papers) and Immunodeficiency and Autoimmune Disorders (9 papers). A. A. McLean collaborates with scholars based in United States. A. A. McLean's co-authors include M. R. Hilleman, Robert E. Weibel, Eugene B. Buynak, A. F. Woodhour, Philip P. Vella, B. J. Neff, W. J. McAleer, J. M. Borgoño, Harry A. Guess and Barbara J. Kuter and has published in prestigious journals such as New England Journal of Medicine, PEDIATRICS and Clinical Infectious Diseases.

In The Last Decade

A. A. McLean

37 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. A. McLean United States 22 1.2k 279 242 195 166 37 1.5k
Robert E. Weibel United States 25 1.8k 1.4× 483 1.7× 346 1.4× 449 2.3× 118 0.7× 72 2.1k
Mary L. Kumar United States 27 1.6k 1.3× 776 2.8× 216 0.9× 147 0.8× 77 0.5× 52 2.1k
Stephen R. Preblud United States 20 1.2k 1.0× 396 1.4× 139 0.6× 563 2.9× 110 0.7× 34 1.6k
Paul D. Parkman United States 21 1.6k 1.3× 607 2.2× 246 1.0× 189 1.0× 126 0.8× 51 2.0k
Lily Yin Weckx Brazil 15 1.1k 0.9× 353 1.3× 250 1.0× 138 0.7× 126 0.8× 53 1.6k
Kenneth L. Herrmann United States 22 943 0.8× 410 1.5× 236 1.0× 348 1.8× 140 0.8× 50 1.4k
Allen Izu United States 23 1.1k 0.9× 322 1.2× 475 2.0× 69 0.4× 205 1.2× 37 2.0k
Toshiaki Ihara Japan 22 1.2k 1.0× 384 1.4× 261 1.1× 89 0.5× 129 0.8× 106 1.6k
Daniel C. William United States 12 810 0.7× 423 1.5× 229 0.9× 122 0.6× 124 0.7× 27 1.4k
B Christenson Sweden 22 1.1k 0.9× 462 1.7× 215 0.9× 367 1.9× 135 0.8× 71 1.7k

Countries citing papers authored by A. A. McLean

Since Specialization
Citations

This map shows the geographic impact of A. A. McLean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. A. McLean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. A. McLean more than expected).

Fields of papers citing papers by A. A. McLean

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. A. McLean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. A. McLean. The network helps show where A. A. McLean may publish in the future.

Co-authorship network of co-authors of A. A. McLean

This figure shows the co-authorship network connecting the top 25 collaborators of A. A. McLean. A scholar is included among the top collaborators of A. A. McLean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. A. McLean. A. A. McLean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dean, Richard T., et al.. (1989). Practical considerations in the production, purification, and formulation of monoclonal antibodies for immunoscintigraphy and immunotherapy. Seminars in Nuclear Medicine. 19(3). 202–220. 15 indexed citations
2.
Weibel, Robert E., B. J. Neff, Barbara J. Kuter, et al.. (1984). Live Attenuated Varicella Virus Vaccine. New England Journal of Medicine. 310(22). 1409–1415. 309 indexed citations
3.
Hilleman, M. R., W. J. McAleer, Eugene B. Buynak, & A. A. McLean. (1983). Quality and safety of human hepatitis B vaccine.. PubMed. 54. 3–12. 12 indexed citations
4.
Hilleman, M. R., et al.. (1983). Stabilized Measles Vaccine in a Novel Single-Dose Delivery System: A Practical Reality for Worldwide Elimination of Measles. Clinical Infectious Diseases. 5(3). 511–513. 4 indexed citations
5.
Hilleman, M. R., W. J. McAleer, Eugene B. Buynak, & A. A. McLean. (1983). The preparation and safety of hepatitis B vaccine. Journal of Infection. 7. 3–8. 31 indexed citations
6.
7.
Neff, B. J., Robert E. Weibel, V. M. Villarejos, et al.. (1981). Clinical and Laboratory Studies of KMcC Strain Live Attenuated Varicella Virus. Experimental Biology and Medicine. 166(3). 339–347. 32 indexed citations
8.
Buynak, Eugene B., et al.. (1980). Persistence of Antibody in Human Subjects for 7 to 10 Years following Administration of Combined Live Attenuated Measles, Mumps, and Rubella Virus Vaccines. Experimental Biology and Medicine. 165(2). 260–263. 43 indexed citations
9.
McAleer, W. J., Henry Z. Markus, A. A. McLean, Eugene B. Buynak, & M. R. Hilleman. (1980). Stability on storage at various temperatures of live measles, mumps and rubella virus vaccines in new stabilizer. Journal of Biological Standardization. 8(4). 281–287. 39 indexed citations
10.
Weibel, Robert E., A. J. Carlson, V. M. Villarejos, et al.. (1980). Clinical and Laboratory Studies of Combined Live Measles, Mumps, and Rubella Vaccines Using the RA 27/3 Rubella Virus. Experimental Biology and Medicine. 165(2). 323–326. 42 indexed citations
11.
Buynak, Eugene B., Robert E. Weibel, A. J. Carlson, A. A. McLean, & M. R. Hilleman. (1979). Further Investigations of Live Respiratory Syncytial Virus Vaccine Administered Parenterally. Experimental Biology and Medicine. 160(2). 272–277. 18 indexed citations
12.
Neff, B. J., Robert E. Weibel, Eugene B. Buynak, A. A. McLean, & M. R. Hilleman. (1979). Clinical and Laboratory Studies of Live Cytomegalovirus Vaccine Ad-169. Experimental Biology and Medicine. 160(1). 32–37. 53 indexed citations
13.
Weibel, Robert E., et al.. (1979). Follow-Up Surveillance for Antibody in Human Subjects following Live Attenuated Measles, Mumps, and Rubella Virus Vaccines. Experimental Biology and Medicine. 162(2). 328–332. 26 indexed citations
14.
Hilleman, M. R., A. A. McLean, Philip P. Vella, Robert E. Weibel, & A. F. Woodhour. (1978). Polyvalent pneumococcal polysaccharide vaccines.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 56(3). 371–5. 25 indexed citations
15.
McLean, A. A., et al.. (1978). Live Respiratory Syncytial Virus Vaccine Administered Parenterally. Experimental Biology and Medicine. 157(4). 636–642. 26 indexed citations
16.
Weibel, Robert E., Eugene B. Buynak, A. A. McLean, & M. R. Hilleman. (1978). Persistence of Antibody After Administration of Monovalent and Combined Live Attenuated Measles, Mumps, and Rubella Virus Vaccines. PEDIATRICS. 61(1). 5–11. 31 indexed citations
17.
Buynak, Eugene B., et al.. (1976). Long-Term Persistence of Antibody following Enders' Original and More Attenuated Live Measles Virus Vaccine. Experimental Biology and Medicine. 153(3). 441–443. 4 indexed citations
18.
Weibel, Robert E., V. M. Villarejos, Philip P. Vella, et al.. (1976). Clinical and Laboratory Investigations of Monovalent and Combined Meningococcal Polysaccharide Vaccines, Groups A and C. Experimental Biology and Medicine. 153(3). 436–440. 12 indexed citations
19.
McAleer, W. J., Eugene B. Buynak, Robert E. Weibel, et al.. (1975). Measles, mumps and rubella virus vaccines prepared from virus produced by unit process. Journal of Biological Standardization. 3(4). 381–384. 4 indexed citations
20.
Weibel, Robert E., A. A. McLean, A. F. Woodhour, Arthur Friedman, & M. R. Hilleman. (1973). Ten-Year Follow-Up Study for Safety of Adjuvant 65 Influenza Vaccine in Man. Experimental Biology and Medicine. 143(4). 1053–1056. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert E. Weibel Breakdown of academic impact, for papers by Mary L. Kumar Breakdown of academic impact, for papers by Stephen R. Preblud Breakdown of academic impact, for papers by Paul D. Parkman Breakdown of academic impact, for papers by Lily Yin Weckx Breakdown of academic impact, for papers by Kenneth L. Herrmann Breakdown of academic impact, for papers by Allen Izu Breakdown of academic impact, for papers by Toshiaki Ihara Breakdown of academic impact, for papers by Daniel C. William Breakdown of academic impact, for papers by B Christenson
Rankless by CCL
2026